# Kidney Stones Market

> Kidney Stone Market Research Report Information by Type (Calcium Oxalate Stones, Uric Acid, Struvite Kidney Stones, Cystine Stones, Calcium Phosphate Stones), Treatment Type (Medications, Extracorporeal Shock Wave Lithotripsy, Ureteroscopy, Percutaneous Nephrolithotomy), Diagnosis (Ultrasound, Intravenous Pyelography, CT scan, X-Ray, Others), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) - Forecast Till 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 4.82%
- **2024:** $ 2,700 Million
- **2025:** $ 2,830.15 Million
- **2035:** $ 4,531.69 Million
- **Key Players:** Boston Scientific (US), Medtronic (US), Johnson & Johnson (US), C.R. Bard (US), Cook Medical (US), Olympus Corporation (JP), Stryker Corporation (US), Terumo Corporation (JP), Karl Storz (DE)

**Report ID:** MRFR/HC/1213-CR · **Pages:** 117 · **Author:** Satyendra Maurya & Kinjoll Dey · **Last Updated:** May 15, 2026

**URL:** https://www.marketresearchfuture.com/reports/kidney-stones-market-1745

---

## Market Summary

## **Global Kidney Stone Market Overview**

Kidney Stone Market Size was valued at USD 2.6 billion in 2023. The Kidney Stone Market industry is projected to grow from USD 2.7 Billion in 2024 to USD 4.4 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.8% during the forecast period (2024 - 2032). 

Growing adoption of minimally invasive stone removal procedures, and advancements in ureteroscopy techniques are the key market drivers boosting the growth of the kidney stone market.

Source Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review

## **Kidney Stone Market Trends**

The rapid adoption of [Minimally Invasive Surgical](../../../reports/minimally-invasive-surgery-devices-market-7875) (MIS) techniques by surgeons has led to a wide variety of applications. In general surgery, minimally invasive methods are being adopted more often than open surgeries. The minimal side effects of MIS procedures compared to open surgery will increase the demand for advanced procedures to manage kidney stones. 

The journal Advances in Chronic Kidney Diseases states that minimally invasive treatments have been widely used for three of the most common stone diseases in America extracorporeal, ureteroscopic, and percutaneous renal lithotomy. Procedures that were previously open to the public are now being performed by minimally invasive surgeons.

## **Kidney Stone Market Segment Insights**

### **Kidney Stone Type Insights**

The kidney stone market segmentation, based on type, includes calcium oxalate stones, uric acid, struvite kidney stones, cystine stones, and calcium phosphate stones. The calcium oxalate stones type segment held the majority share in 2022 with respect to the kidney stone market revenue. This is primarily owing to the high level of oxalate in the urine and lesser intake of water. Also, various risk factors including intake of a diet containing high levels of protein, oxalate, sodium, or sugar may result in calcium oxalate stones formation.

**March 2024:** Boston Scientific has introduced the LithoVue Empower Retrieval Deployment Device, a new tool that improves the efficiency of stone retrieval during ureteroscopy. This device allows urologists to perform single-handed stone retrieval, reducing procedure time and improving patient outcomes, marking a significant advancement in endoscopic kidney stone management.

**February 2024:** Olympus Corporation has introduced its next-generation flexible ureteroscope, designed for all kidney stone types. This innovative device offers improved maneuverability, high-definition imaging, and improved visualization, enabling more effective treatment across all stone types. Its ergonomic design and advanced optics enhance procedural efficiency and patient comfort.

### **Kidney Stone Treatment Type Insights**

The kidney stone market segmentation, based on treatment type, includes medications, extracorporeal shock wave lithotripsy, ureteroscopy, and percutaneous nephrolithotomy. The ureteroscopy segment dominated the market in 2022 with respect to the  kidney stone market revenue. This is due to the offering to break up stones, take out suspicious-looking tissue, and have an unobstructed urinary tract view.

### **Kidney Stone Diagnosis Insights**

The  kidney stone Market segmentation, based on diagnosis includes ultrasound, intravenous pyelography, CT scan, x-ray, and others. Ultrasound held the largest market share in 2022 with respect to the  kidney stone market revenue. This is attributed to the no exposure to radiation, the growing popularity, and the showing of anatomical detail of the kidney in a very less time. It is a safe and painless test that uses sound waves to make images of the kidneys, ureters, and bladder.

**April 2024:** Siemens Healthcare has introduced the Naeotom Alpha, a photon-counting CT scanner, which offers high-resolution imaging for kidney stone detection. This innovative technology reduces radiation exposure and improves the accuracy of kidney stone diagnosis, including the detection of smaller stones and differentiation between stone types.

**March 2024:** Boston Scientific has launched the VersaWave Ultrasound System, a portable diagnostic tool for point-of-care kidney stone detection. This high-frequency imaging device, with enhanced Doppler capabilities, is particularly useful in emergency and outpatient settings, providing quick and reliable diagnostic information.

**Figure 2 Kidney Stone Market, by Diagnosis, 2022 & 2030 (USD Billion)**

**_Source Secondary Research, Primary Research, MRFR Database and Analyst Review_**

### **Kidney Stone Regional Insights**

By Region, the study segments the market into North America, Europe, Asia-Pacific, and the Rest of the World. North America kidney stone held the largest market share in 2022. This is attributed to the developed healthcare infrastructure, favorable government policies, and presence of major key companies headquarters in the region are driving the market in the region. Additionally, it is projected that supportive government measures and an increase in research collaborations will accelerate industry development.

Further, the major countries studied are The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

**Figure 3 KIDNEY STONE MARKET SIZE BY REGION 2022 & 2030 (USD Billion)**

**_Source Secondary Research, Primary Research, MRFR Database and Analyst Review_**

Europe kidney stone market accounts for the second-largest market share due to the increasing prevalence of kidney stone disease and the rise in the elderly population across Europe. However, the lack of awareness regarding renal stones hinders market growth. Further, the Germany kidney stone market held the largest market share, and the UK kidney stone market was the fastest-growing market in the European region.

The Asia-Pacific kidney stone market is expected to grow at a significant growth rate during the forecast period. This is due to the rising incidence of kidney stones, the rapidly building healthcare infrastructure, the growing government support, and the rising number of startups in this region. Moreover, China kidney stone market held the largest market share, and the India kidney stone market was the fastest-growing market in the Asia-Pacific region. Hence, Asia-Pacific is anticipated to register the highest growth rate over the forecast period from 2024–2032.

**Kidney Stone Key Market Players & Competitive Insights**

Major market players are spending a lot of money on R&D to increase their product lines, which will help the kidney stone market grow even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, including new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the kidney stone industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment. 

One of the primary business strategies adopted by manufacturers in the  kidney stone industry to benefit clients and expand the kidney stone market sector is to manufacture locally to reduce operating costs.

Boston Scientific Corporation (US) is a worldwide developer, manufacturer, and marketer of medical devices used in a range of interventional medical specialties. The company collaborates with healthcare professionals to develop a broad portfolio of meaningful innovations that improve outcomes, reduce costs, and increase efficiencies. Its product portfolio is majorly divided into endoscopy, interventional cardiology, neuromodulation, peripheral interventions, rhythm management, and urology & pelvic health. In September 2021, Boston Scientific Corporation acquired a  surgical business of Lumenis Ltd. (Israel) a privately held company that develops and commercializes energy-based medical solutions, from an affiliate of Baring Private Equity Asia (BPEA).

The Lumenis surgical business includes premier laser systems, fibers, and accessories used for urology and otolaryngology procedures.

**Key Companies in the Kidney Stone Market Includes**

### Kidney Stones Market Industry Developments

- **Q2 2024: Boston Scientific Announces FDA Clearance of Next-Generation LithoVue™ Elite Single-Use Digital Flexible Ureteroscope** Boston Scientific received FDA clearance for its LithoVue™ Elite, a next-generation single-use digital flexible ureteroscope designed for kidney stone management, enhancing visualization and data integration for urologists.
- **Q2 2024: Olympus Launches Soltive™ SuperPulsed Laser System for Kidney Stone Treatment in Europe** Olympus announced the European launch of its Soltive™ SuperPulsed Laser System, a new device for minimally invasive kidney stone treatment, expanding its urology portfolio.
- **Q3 2024: Urotronic Receives CE Mark Approval for Optilume® Urethral Drug-Coated Balloon for Urolithiasis** Urotronic secured CE Mark approval for its Optilume® drug-coated balloon, enabling its use in the European market for the treatment of urethral strictures associated with kidney stone disease.
- **Q3 2024: Medtronic Acquires StoneClear Medical to Expand Kidney Stone Management Portfolio** Medtronic completed the acquisition of StoneClear Medical, a startup specializing in advanced kidney stone removal devices, strengthening its position in the urology device market.
- **Q2 2024: Dornier MedTech Opens New Manufacturing Facility in Singapore for Kidney Stone Devices** Dornier MedTech inaugurated a new manufacturing facility in Singapore dedicated to the production of its kidney stone management devices, aiming to meet growing global demand.
- **Q1 2025: Coloplast Announces $200 Million Investment in Urology R&D, Focus on Kidney Stone Solutions** Coloplast revealed a $200 million investment in research and development for urology, with a significant portion allocated to developing new kidney stone management technologies.
- **Q2 2025: Boston Scientific Launches LithoVue™ Elite in Asia-Pacific Markets** Boston Scientific expanded the availability of its LithoVue™ Elite single-use digital flexible ureteroscope to Asia-Pacific markets, following regulatory approvals in several countries.
- **Q1 2024: FDA Approves New Indication for ShockPulse-SE Lithotripter in Pediatric Kidney Stone Patients** The FDA granted approval for the use of the ShockPulse-SE Lithotripter in pediatric patients, broadening treatment options for children with kidney stones.
- **Q3 2024: Olympus Partners with Medispec to Co-Develop Next-Generation Lithotripsy System** Olympus entered a partnership with Medispec to co-develop a next-generation lithotripsy system aimed at improving the efficiency and safety of kidney stone fragmentation.
- **Q2 2024: Urotronic Raises $40 Million in Series C Funding to Advance Kidney Stone Device Pipeline** Urotronic closed a $40 million Series C funding round to accelerate the development and commercialization of its minimally invasive devices for kidney stone management.
- **Q4 2024: Coloplast Receives FDA Clearance for New Ureteral Stent for Kidney Stone Patients** Coloplast obtained FDA clearance for its latest ureteral stent, designed to improve patient comfort and outcomes in kidney stone management.
- **Q1 2025: Medtronic Appoints New Head of Urology Division Amid Kidney Stone Market Expansion** Medtronic appointed a new executive to lead its urology division, signaling a strategic focus on expanding its kidney stone management business.

## **Kidney Stone Market Segmentation**

### **Kidney Stone Type Outlook**

### **Kidney Stone Treatment Type Outlook**

### **Kidney Stone Diagnosis Outlook**

### **Kidney Stone Regional Outlook**

## Market Drivers

### Rising Healthcare Expenditure

The upward trend in healthcare expenditure is influencing the Kidney Stones Market. As countries allocate more resources to healthcare, there is a corresponding increase in funding for research and development in the field of urology. This financial commitment fosters innovation and the introduction of new treatment modalities for kidney stones. Additionally, higher healthcare spending often translates to improved access to medical services, enabling more patients to seek treatment for kidney stones. This trend is particularly evident in regions where healthcare systems are evolving to meet the demands of their populations. As a result, the Kidney Stones Market is likely to benefit from increased investment in healthcare infrastructure and services, ultimately enhancing patient care and treatment outcomes.

### Rising Incidence of Kidney Stones

The increasing prevalence of kidney stones is a primary driver of the Kidney Stones Market. Recent data indicates that approximately 10 percent of the population will experience a kidney stone at some point in their lives. This rising incidence is attributed to various factors, including dietary habits, obesity, and dehydration. As more individuals are diagnosed with kidney stones, the demand for effective treatment options and preventive measures escalates. This trend is likely to propel the growth of the Kidney Stones Market, as healthcare providers seek innovative solutions to manage and treat this condition. Furthermore, the economic burden associated with kidney stones, including hospitalizations and treatment costs, underscores the necessity for advancements in this market.

### Advancements in Medical Technology

Technological innovations in the medical field are significantly influencing the Kidney Stones Market. The development of minimally invasive surgical techniques, such as ureteroscopy and laser lithotripsy, has transformed the treatment landscape for kidney stones. These advancements not only enhance patient outcomes but also reduce recovery times and hospital stays. Moreover, the integration of imaging technologies, such as ultrasound and CT scans, facilitates accurate diagnosis and treatment planning. As healthcare providers increasingly adopt these advanced technologies, the Kidney Stones Market is poised for growth. The potential for new devices and treatment modalities to emerge further indicates a dynamic market environment, where continuous improvement in patient care remains a priority.

### Aging Population and Chronic Conditions

The aging population is a significant driver of the Kidney Stones Market. As individuals age, the likelihood of developing kidney stones increases due to various factors, including changes in metabolism and the prevalence of chronic conditions such as diabetes and hypertension. This demographic shift is expected to result in a higher incidence of kidney stones, thereby increasing the demand for treatment options. Furthermore, the aging population often requires more comprehensive healthcare services, which may include specialized care for kidney stone management. Consequently, the Kidney Stones Market is likely to expand as healthcare systems adapt to meet the needs of this growing demographic, ensuring that effective treatment options are readily available.

### Increased Focus on Preventive Healthcare

The growing emphasis on preventive healthcare is shaping the Kidney Stones Market. As awareness of the importance of lifestyle choices in preventing kidney stones rises, individuals are more inclined to adopt healthier diets and hydration practices. This shift is reflected in the increasing demand for dietary supplements and educational resources aimed at preventing kidney stones. Additionally, healthcare providers are prioritizing preventive measures, leading to the development of programs and initiatives focused on educating patients about risk factors and management strategies. This proactive approach not only benefits patients but also contributes to the overall growth of the Kidney Stones Market, as it encourages the development of products and services tailored to prevention.

## Future Outlook

The Kidney Stones Market is projected to grow at a 4.82% CAGR from 2024 to 2035, driven by increasing prevalence, advancements in treatment technologies, and rising healthcare expenditure.

**New opportunities:**

- Development of minimally invasive surgical techniques for stone removal. Expansion of telehealth services for [remote patient monitoring](https://www.marketresearchfuture.com/reports/remote-patient-monitoring-market-10905) and consultations. Investment in AI-driven diagnostic tools for early detection of kidney stones.

By 2035, the Kidney Stones Market is expected to achieve substantial growth and innovation.

## Segment Insights

### By Type of Kidney Stones: Calcium Oxalate (Largest) vs. Uric Acid (Fastest-Growing)

The Kidney Stones Market is significantly driven by the prevalence of different types of kidney stones, with Calcium Oxalate stones being the most common, holding the largest market share. Uric Acid stones, while less prevalent than Calcium Oxalate, are emerging rapidly due to various factors including dietary changes and lifestyle diseases. Struvite and Cystine stones account for a smaller portion of the market, but they also play a crucial role in the overall landscape of kidney stone composition.

Calcium Oxalate (Dominant) vs. Uric Acid (Emerging)

Calcium Oxalate stones are the dominant type in the kidney stones market, primarily due to their high incidence linked to diet and genetic factors. Patients suffering from conditions such as hypercalciuria often experience this type of stone. On the other hand, Uric Acid stones are emerging as a significant concern, especially among individuals with diets rich in purines, contributing to a rising incidence. Their formation is influenced by factors like obesity and metabolic syndrome, making them a growing focus in patient management and preventive strategies. Together, these types define the landscape of kidney stone challenges faced in today's healthcare setting.

### By Treatment Method: Medication (Largest) vs. Surgery (Fastest-Growing)

The distribution of market share among the treatment methods for kidney stones reveals that medication remains the largest segment, successfully catering to patients seeking non-invasive solutions. This approach benefits from ongoing advancements in pharmaceutical research, which continuously enhance drug efficacy and patient outcomes. Conversely, surgery, while holding a smaller share, is identified as the fastest-growing segment due to increasing incidences of complex kidney stone cases and the advancement in surgical techniques, providing better recovery time and outcomes for patients.

Medication: Dominant vs. Surgery: Emerging

Medication is characterized by its non-invasive approach, allowing patients to manage kidney stones with pain relief and stone dissolution treatments. The continuous innovation in pharmaceuticals and the growing preference for conservative management contribute to its dominance in the market. On the other hand, surgery is emerging rapidly, driven by advancements in techniques such as laparoscopic surgery and robotic assistance. This method is increasingly favored for patients with large or recurrent stones, as it significantly decreases recovery time and improves procedural success rates, making it a vital alternative in the overall treatment landscape.

### By Diagnosis Method: CT Scan (Largest) vs. Ultrasound (Fastest-Growing)

In the Kidney Stones Market, the diagnosis methods exhibit a varied distribution of market share. CT Scan stands out as the largest segment, favored for its high accuracy and quick results, which many healthcare providers prefer. Ultrasound, while currently holding a smaller market share, is rapidly gaining traction due to its non-invasive nature and growing acceptance in clinical practices. As a whole, this segment captures the diverse preferences in diagnostic approaches among healthcare professionals, reflecting the demand for effective diagnosis.

CT Scan (Dominant) vs. Ultrasound (Emerging)

CT Scan is seen as the dominant diagnosis method due to its exceptional precision in identifying kidney stones. Its ability to provide detailed images within a short time contributes significantly to its preference among urologists and emergency departments. However, Ultrasound is emerging as a viable alternative, particularly in pediatric cases and in settings where radiation exposure is a concern. The growth of Ultrasound is propelled by advancements in technology making it more accessible, along with increasing awareness of the benefits of radiation-free imaging, positioning it as an indispensable tool in the evolving landscape of kidney stone diagnosis.

### By Patient Demographics: Age Group (Largest) vs. Gender (Fastest-Growing)

In the Kidney Stones Market, the distribution of patients by age group indicates that individuals aged 30 to 50 years represent the largest segment, significantly impacting the overall market. This demographic holds a notable portion of the market due to lifestyle factors and increased prevalence of kidney stones within this age range. Gender distribution shows a growing trend, particularly among females, as awareness and diagnosis improve, making it a key area for growth in upcoming years.

Age Group: 30-50 (Dominant) vs. Gender: Female (Emerging)

The age group of 30 to 50 years is currently the dominant demographic in the Kidney Stones Market, primarily due to the combination of lifestyle choices, dietary habits, and increased susceptibility that come with age. This group frequently experiences the implications of sedentary lifestyles and dietary influences, which contribute to stone formation. Conversely, the female demographic is emerging as a significant player in this market. With an increasing awareness of kidney health among women and outreach programs targeting female patients, this group shows potential for rapid growth and is likely to become an essential part of future market strategies.

## Regional Market Share Analysis

### North America : Market Leader in Innovation

North America holds a commanding position in the kidney stones market, with a market size of $1350.0 million in 2024. The region's growth is driven by increasing prevalence of kidney stones, advancements in medical technology, and supportive healthcare policies. Regulatory catalysts, such as FDA approvals for innovative treatment devices, further enhance market dynamics. The rising awareness of preventive healthcare and lifestyle changes also contribute to the growing demand for effective treatment options. The competitive landscape in North America is characterized by the presence of major players like Boston Scientific, Medtronic, and Johnson & Johnson. These companies are at the forefront of developing cutting-edge technologies and minimally invasive procedures. The U.S. remains the leading country, accounting for a significant share of the market, while Canada is also witnessing growth due to increasing healthcare investments and a rising patient population.

### Europe : Emerging Market with Growth Potential

Europe's kidney stones market is valued at $810.0 million, reflecting a growing demand for advanced treatment options. Factors such as an aging population, rising obesity rates, and increased awareness of kidney health are driving market growth. Regulatory frameworks in the EU promote innovation and ensure patient safety, which is crucial for market expansion. The region is also witnessing a shift towards minimally invasive procedures, enhancing patient outcomes and satisfaction. Leading countries in Europe include Germany, France, and the UK, where healthcare systems are increasingly adopting advanced technologies. Key players like Karl Storz and Olympus Corporation are actively involved in research and development, contributing to the competitive landscape. The presence of robust healthcare infrastructure and favorable reimbursement policies further support market growth, positioning Europe as a significant player in The Kidney Stones.

### Asia-Pacific : Rapidly Growing Healthcare Sector

The Asia-Pacific kidney stones market is valued at $450.0 million, driven by rising healthcare expenditures and increasing prevalence of kidney stones. Countries like China and India are experiencing a surge in demand for effective treatment options due to lifestyle changes and dietary habits. Government initiatives aimed at improving healthcare access and affordability are also contributing to market growth. The region is witnessing a trend towards adopting advanced medical technologies, enhancing treatment efficacy. In the competitive landscape, key players such as Terumo Corporation and Olympus Corporation are expanding their presence in Asia-Pacific. The market is characterized by a mix of local and international companies, fostering innovation and competition. As healthcare infrastructure improves, the region is poised for significant growth, making it an attractive market for investment and development in kidney stone treatments.

### Middle East and Africa : Emerging Market with Challenges

The Middle East and Africa (MEA) kidney stones market is valued at $90.0 million, reflecting a nascent but growing sector. The region faces challenges such as limited healthcare access and varying levels of awareness about kidney health. However, increasing urbanization and lifestyle changes are contributing to a rise in kidney stone cases, driving demand for treatment options. Government initiatives aimed at improving healthcare infrastructure are expected to support market growth in the coming years. Leading countries in the MEA region include South Africa and the UAE, where healthcare systems are gradually adopting advanced medical technologies. The competitive landscape is evolving, with both local and international players seeking to establish a foothold. As awareness of kidney health increases, the market is likely to attract investments, paving the way for innovative treatment solutions.

## Competitive Benchmarking

The Kidney Stones Market is characterized by a competitive landscape that is increasingly shaped by innovation, strategic partnerships, and a focus on patient-centric solutions. Key players such as Boston Scientific (US), Medtronic (US), and Johnson & Johnson (US) are actively pursuing strategies that emphasize technological advancements and operational efficiencies. For instance, Boston Scientific (US) has been focusing on expanding its product portfolio through innovative solutions that enhance patient outcomes, while Medtronic (US) is leveraging its extensive research capabilities to develop minimally invasive procedures that cater to the growing demand for less invasive treatment options. Johnson & Johnson (US), on the other hand, appears to be concentrating on strategic acquisitions to bolster its market presence and diversify its offerings, thereby shaping a competitive environment that is both dynamic and multifaceted.
In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and improve supply chain efficiency. This approach not only enhances responsiveness to market demands but also mitigates risks associated with global supply chain disruptions. The competitive structure of the market is moderately fragmented, with several players vying for market share. However, the collective influence of major companies is significant, as they drive innovation and set industry standards that smaller players often follow.
In January 2026, Medtronic (US) announced the launch of a new line of advanced ureteral stents designed to improve patient comfort and reduce complications associated with kidney stone procedures. This strategic move is likely to enhance Medtronic's competitive edge by addressing specific patient needs and reinforcing its commitment to innovation in urology. The introduction of these stents may also position the company favorably against competitors who have yet to innovate in this area.
In December 2025, Boston Scientific (US) entered into a partnership with a leading telehealth provider to integrate remote monitoring solutions into its kidney stone treatment protocols. This collaboration is indicative of a broader trend towards digital health solutions, which could potentially transform patient management and follow-up care. By embracing telehealth, Boston Scientific (US) not only enhances its service offerings but also aligns itself with the growing demand for digital health solutions in the medical field.
In November 2025, Johnson & Johnson (US) completed the acquisition of a startup specializing in AI-driven diagnostic tools for kidney stones. This acquisition is strategically significant as it allows Johnson & Johnson (US) to integrate cutting-edge technology into its existing product lines, thereby enhancing diagnostic accuracy and treatment efficacy. The move underscores the importance of technological integration in maintaining a competitive advantage in the market.
As of February 2026, current trends in the Kidney Stones Market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in driving innovation and expanding market reach. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This shift suggests that companies that prioritize these elements will be better positioned to thrive in an increasingly complex and competitive landscape.

## Recent News & Developments

- **Q2 2024: Boston Scientific Announces FDA Clearance of Next-Generation LithoVue™ Elite Single-Use Digital Flexible [Ureteroscope](https://www.marketresearchfuture.com/reports/ureteroscope-market-42192)**[](https://www.marketresearchfuture.com/reports/ureteroscope-market-42192)Boston Scientific received FDA clearance for its LithoVue™ Elite, a next-generation single-use digital flexible ureteroscope designed for kidney stone management, enhancing visualization and data integration for urologists.
- **Q2 2024: Olympus Launches Soltive™ SuperPulsed Laser System for Kidney Stone Treatment in Europe** Olympus announced the European launch of its Soltive™ SuperPulsed Laser System, a new device for minimally invasive kidney stone treatment, expanding its urology portfolio.
- **Q3 2024: Urotronic Receives CE Mark Approval for Optilume® Urethral Drug-Coated Balloon for Urolithiasis** Urotronic secured CE Mark approval for its Optilume® drug-coated balloon, enabling its use in the European market for the treatment of urethral strictures associated with kidney stone disease.
- **Q3 2024: Medtronic Acquires StoneClear Medical to Expand Kidney Stone Management Portfolio** Medtronic completed the acquisition of StoneClear Medical, a startup specializing in advanced kidney stone removal devices, strengthening its position in the urology device market.
- **Q2 2024: Dornier MedTech Opens New Manufacturing Facility in Singapore for Kidney Stone Devices** Dornier MedTech inaugurated a new manufacturing facility in Singapore dedicated to the production of its kidney stone management devices, aiming to meet growing global demand.
- **Q1 2025: Coloplast Announces $200 Million Investment in Urology R&D, Focus on Kidney Stone Solutions** Coloplast revealed a $200 million investment in research and development for urology, with a significant portion allocated to developing new kidney stone management technologies.
- **Q2 2025: Boston Scientific Launches LithoVue™ Elite in Asia-Pacific Markets** Boston Scientific expanded the availability of its LithoVue™ Elite single-use digital flexible ureteroscope to Asia-Pacific markets, following regulatory approvals in several countries.
- **Q1 2024: FDA Approves New Indication for ShockPulse-SE Lithotripter in Pediatric Kidney Stone Patients** The FDA granted approval for the use of the ShockPulse-SE Lithotripter in pediatric patients, broadening treatment options for children with kidney stones.
- **Q3 2024: Olympus Partners with Medispec to Co-Develop Next-Generation Lithotripsy System** Olympus entered a partnership with Medispec to co-develop a next-generation lithotripsy system aimed at improving the efficiency and safety of kidney stone fragmentation.
- **Q2 2024: Urotronic Raises $40 Million in Series C Funding to Advance Kidney Stone Device Pipeline** Urotronic closed a $40 million Series C funding round to accelerate the development and commercialization of its [minimally invasive devices](https://www.marketresearchfuture.com/reports/minimally-invasive-devices-market-43705) for kidney stone management.
- **Q4 2024: Coloplast Receives FDA Clearance for New Ureteral Stent for Kidney Stone Patients** Coloplast obtained FDA clearance for its latest ureteral stent, designed to improve patient comfort and outcomes in kidney stone management.
- **Q1 2025: Medtronic Appoints New Head of Urology Division Amid Kidney Stone Market Expansion** Medtronic appointed a new executive to lead its urology division, signaling a strategic focus on expanding its kidney stone management business.

## Report Scope

| MARKET SIZE 2024 | 2700.0(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 2830.15(USD Million) |
| MARKET SIZE 2035 | 4531.69(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 4.82% (2024 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Boston Scientific (US), Medtronic (US), Johnson & Johnson (US), C.R. Bard (US), Cook Medical (US), Olympus Corporation (JP), Stryker Corporation (US), Terumo Corporation (JP), Karl Storz (DE) |
| Segments Covered | Type of Kidney Stones, Treatment Method, Diagnosis Method, Patient Demographics |
| Key Market Opportunities | Advancements in minimally invasive treatment technologies enhance patient outcomes in the Kidney Stones Market. |
| Key Market Dynamics | Rising prevalence of kidney stones drives demand for innovative treatment options and advanced diagnostic technologies. |
| Countries Covered | North America, Europe, APAC, South America, MEA |

## Frequently Asked Questions

**Q: What is the current valuation of the Kidney Stones Market as of 2026?**
A: The Kidney Stones Market is valued at approximately 2700.0 USD Million in 2024.

**Q: What is the projected market valuation for the Kidney Stones Market in 2035?**
A: The market is projected to reach approximately 4531.69 USD Million by 2035.

**Q: What is the expected CAGR for the Kidney Stones Market during the forecast period 2025 - 2035?**
A: The expected CAGR for the Kidney Stones Market during the forecast period 2025 - 2035 is 4.82%.

**Q: Which companies are considered key players in the Kidney Stones Market?**
A: Key players in the market include Boston Scientific, Medtronic, Johnson & Johnson, and C.R. Bard.

**Q: What are the primary types of kidney stones and their market valuations?**
A: The primary types of kidney stones include Calcium Oxalate valued at 1350.0 to 2250.0 USD Million, Uric Acid at 810.0 to 1350.0 USD Million, Struvite at 360.0 to 600.0 USD Million, and Cystine at 180.0 to 300.0 USD Million.

**Q: What treatment methods are available for kidney stones and their market values?**
A: Treatment methods include Medication valued at 810.0 to 1350.0 USD Million, Surgery at 810.0 to 1350.0 USD Million, Extracorporeal Shock Wave Lithotripsy at 540.0 to 900.0 USD Million, and Ureteroscopy at 540.0 to 900.0 USD Million.

**Q: What diagnostic methods are utilized in the Kidney Stones Market and their valuations?**
A: Diagnostic methods include Ultrasound valued at 540.0 to 900.0 USD Million, CT Scan at 810.0 to 1350.0 USD Million, X-ray at 540.0 to 900.0 USD Million, and Urinalysis at 810.0 to 1350.0 USD Million.

**Q: How do patient demographics influence the Kidney Stones Market?**
A: Patient demographics, including Age Group valued at 540.0 to 900.0 USD Million, Gender at 450.0 to 750.0 USD Million, and Lifestyle Factors at 810.0 to 1350.0 USD Million, play a crucial role in market dynamics.

**Q: What geographic distribution trends are observed in the Kidney Stones Market?**
A: Geographic distribution is valued at approximately 900.0 to 1531.69 USD Million, indicating varying prevalence across regions.

**Q: How does the competitive landscape of the Kidney Stones Market appear in 2026?**
A: The competitive landscape appears robust, with major players like Stryker Corporation and Olympus Corporation actively participating in market growth.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/kidney-stones-market-1745*